ˋQu谷 papel ocupan los ARA-II en el tratamiento de la insuficiencia cardiaca?: ˋActuamos por evidencias/recomendaciones o por la presi車n de la industria farmac谷utica?

作者：Fuente Cid; R de la; Varela Roman; A

来源：Anales de Medicina Interna, 2007.

DOI：10.4321/S0212-71992007001200011

• cronic heart failure
• angiotensin receptor blockers.

chronic heart failure (chf) represents the first cause of hospitalitation in persons older than 60 years in our enviroment. beside its incidence and prevalence is increasing although new therapeutic treatments. we think the recomendations of the guidelines of clinical practise are an important instrument to make decisions, although sometimes it is used a numeric language little clear. we do not have either to forget that sometimes patients selected for the clinical trials aren∩t really representative. finally to add that pharmaceutical industry spends a lot of money on investigating active basics, but as company itself is needs to obtain benefits. with all of this, in this article we try to study the role of angiotensin ii receptor blockers (arbs) occuppy in the medic strategy for the planification of a patient%26apos;s treatment with chronic heart failure.